OxyContin manufacturer Purdue Pharma won court approval for an opioid-related settlement plan of at least $7.4 billion, clearing its path to exit from a six-year bankruptcy and resolve mass lawsuits against the company for fueling addiction.
Becky Yerak is a Bankruptcy Reporter at The Wall Street Journal. She covers topics related to bankruptcy and financial news, drawing on her extensive experience in the field. Becky has been featured in Financial News, MarketWatch, Yahoo Finance, LiveMint, and MSN, showcasing her expertise and insights into the world of finance.







